Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
These data were first presented by Nakul Ganju, MD, of Howard University Hospital, Washington, DC, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Adequate protein: Helps maintain muscle mass during weight loss and supports satiety
Use clean syringes and sterile water to prepare your solution
If you experience any restriction sensations, size up or choose a more flexible fabric blend with elastane/spandex content